Kantinan Chuensirikulchai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kantinan Chuensirikulchai has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Nuchjira Takheaw
Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
2 shared publications - Supansa Pata
Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
2 shared publications - Watchara Kasinrerk
Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
2 shared publications - Witida Laopajon
Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
2 shared publications - Annie Elong Ngono
Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, USA
1 shared publication - Athavudh Deesomchok
Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
1 shared publication
Latest Publications
- Open Access
- 26 August 2026
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (10) , 2867-2882
A Zika virus vaccine with E protein fusion loop mutations protects via CD8+ T cells
- 26 August 2026
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (10) , 2867-2882
Open AccessA Zika virus vaccine with E protein fusion loop mutations protects via CD8+ T cells
- Open Access
- 1 January 2025
- Published by XMLink in Infection & Chemotherapy
- Vol. 57 (2) , 274-287
Immune Responses Against SARS-CoV-2 in Previously SARS-CoV-2-Infected Individuals after Receiving a Single Dose of CoronaVac or ChAdOx-1 Vaccine
Laopajon W, et al. Infect Chemother. 2025 Apr;57:e25. https://doi.org/10.3947/ic.2024.0145
- 1 January 2025
- Published by XMLink in Infection & Chemotherapy
- Vol. 57 (2) , 274-287
Open AccessImmune Responses Against SARS-CoV-2 in Previously SARS-CoV-2-Infected Individuals after Receiving a Single Dose of CoronaVac or ChAdOx-1 Vaccine
Laopajon W, et al. Infect Chemother. 2025 Apr;57:e25. https://doi.org/10.3947/ic.2024.0145
- 24 June 2024
- Published by Wiley in Immunology
- Vol. 173 (2) , 321-338
Identification of different functions of CD8+ T cell subpopulations by a novel monoclonal antibody
The explicit identification of CD8+ T cell subpopulation is important for deciphering the role of CD8+ T cells for protecting our body against invading pathogens and cancer. Our generated monoclonal antibody (mAb), named FE‐1H10, recognized two novel subpopulations of peripheral blood CD8+ T cells, FE‐1H10+ and FE‐1H10− CD8+ T cells. The molecule recognized by mAb FE‐1H10 (FE‐1H10 molecules) had a higher distribution on effector memory CD8+ T cell subsets. The functions of FE‐1H10− and FE‐1H10+ CD8+ T cells were investigated. T cell proliferation assays revealed that FE‐1H10− CD8+ T cells exhibited a higher proliferation rate than FE‐1H10+ CD8+ T cells, whereas FE‐1H10+ CD8+ T cells produced higher levels of IFN‐γ and TNF‐α than FE‐1H10− CD8+ T cells. In T cell cytotoxicity assays, FE‐1H10+ CD8+ T cells were able to kill target cells better than FE‐1H10− CD8+ T cells. RNA‐sequencing analysis confirmed that these subpopulations were distinct: FE‐1H10+ CD8+ T cells have higher expression of genes involved in effector functions (IFNG, TNF, GZMB, PRF1, GNLY, FASL, CX3CR1) while FE‐1H10− CD8+ T cells have greater expression of genes related to memory CD8+ T cell populations (CCR7, SELL, TCF7, CD40LG). The results suggested that mAb FE‐1H10 identifies two novel distinctive CD8+ T cell subpopulations. The FE‐1H10+ CD8+ T cells carried a superior functionality in response to tumour cells. The uncover of these novel CD8+ T cell subpopulations may be the basis knowledge of an optional immunotherapy for the selection of potential CD8+ T cells in cancer treatment.
- 24 June 2024
- Published by Wiley in Immunology
- Vol. 173 (2) , 321-338
Identification of different functions of CD8+ T cell subpopulations by a novel monoclonal antibody
The explicit identification of CD8+ T cell subpopulation is important for deciphering the role of CD8+ T cells for protecting our body against invading pathogens and cancer. Our generated monoclonal antibody (mAb), named FE‐1H10, recognized two novel subpopulations of peripheral blood CD8+ T cells, FE‐1H10+ and FE‐1H10− CD8+ T cells. The molecule recognized by mAb FE‐1H10 (FE‐1H10 molecules) had a higher distribution on effector memory CD8+ T cell subsets. The functions of FE‐1H10− and FE‐1H10+ CD8+ T cells were investigated. T cell proliferation assays revealed that FE‐1H10− CD8+ T cells exhibited a higher proliferation rate than FE‐1H10+ CD8+ T cells, whereas FE‐1H10+ CD8+ T cells produced higher levels of IFN‐γ and TNF‐α than FE‐1H10− CD8+ T cells. In T cell cytotoxicity assays, FE‐1H10+ CD8+ T cells were able to kill target cells better than FE‐1H10− CD8+ T cells. RNA‐sequencing analysis confirmed that these subpopulations were distinct: FE‐1H10+ CD8+ T cells have higher expression of genes involved in effector functions (IFNG, TNF, GZMB, PRF1, GNLY, FASL, CX3CR1) while FE‐1H10− CD8+ T cells have greater expression of genes related to memory CD8+ T cell populations (CCR7, SELL, TCF7, CD40LG). The results suggested that mAb FE‐1H10 identifies two novel distinctive CD8+ T cell subpopulations. The FE‐1H10+ CD8+ T cells carried a superior functionality in response to tumour cells. The uncover of these novel CD8+ T cell subpopulations may be the basis knowledge of an optional immunotherapy for the selection of potential CD8+ T cells in cancer treatment.
- Open Access
- 12 March 2019
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 31 (8) , 515-530
Characterization and functional analysis of novel circulating NK cell sub-populations
Natural killer (NK) cells are innate lymphoid cells having potent cytolytic function that provide host defense against microbial infections and tumors. Using our generated monoclonal antibody (mAb), named FE-1H10, new NK cell sub-populations in peripheral blood were identified. The molecules recognized by mAb FE-1H10 were expressed on a sub-population of CD3−CD56dim NK cells. The epitope recognized by mAb FE-1H10 was demonstrated to be N-glycan and proven to be different from CD57. Upon K562 stimulation, the CD56dimFE-1H10+ NK cell sub-population exhibited significantly lower cytolytic function with low ability to degranulate and release cytolytic granules compared to the CD56dimFE-1H10− NK cell sub-population. Moreover, the CD56dimFE-1H10+ NK cells produced less IFN-γ and TNF-α than the CD56dimFE-1H10− NK cells. We demonstrated here that mAb FE-1H10 could identify two sub-populations of circulating CD56dim NK cells with different functions. Our discovery of new sub-populations of NK cells improves our understanding of NK cell biology and may lead to the development of new approaches for NK cell therapy.
- 12 March 2019
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 31 (8) , 515-530
Open AccessCharacterization and functional analysis of novel circulating NK cell sub-populations
Natural killer (NK) cells are innate lymphoid cells having potent cytolytic function that provide host defense against microbial infections and tumors. Using our generated monoclonal antibody (mAb), named FE-1H10, new NK cell sub-populations in peripheral blood were identified. The molecules recognized by mAb FE-1H10 were expressed on a sub-population of CD3−CD56dim NK cells. The epitope recognized by mAb FE-1H10 was demonstrated to be N-glycan and proven to be different from CD57. Upon K562 stimulation, the CD56dimFE-1H10+ NK cell sub-population exhibited significantly lower cytolytic function with low ability to degranulate and release cytolytic granules compared to the CD56dimFE-1H10− NK cell sub-population. Moreover, the CD56dimFE-1H10+ NK cells produced less IFN-γ and TNF-α than the CD56dimFE-1H10− NK cells. We demonstrated here that mAb FE-1H10 could identify two sub-populations of circulating CD56dim NK cells with different functions. Our discovery of new sub-populations of NK cells improves our understanding of NK cell biology and may lead to the development of new approaches for NK cell therapy.